Vue transversale de la maladie
Myopathies
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1012 résultats correspondants
· 46 visibles sur cette page
dans le périmètre Myopathies
Niveau clinique
Études et traitements 421
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Semaglutide (Rybelsus®) NCT07642635 · Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individ… | Myopathies | Traitement symptomatique | Phase 1/2 | NOT_YET_RECRUITING | Duchenne Muscular Dystrophy (DMD) is a rare, genetic disease that leads to… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:44 | Détail |
| Skeletal muscle biopsy (residual specimen) NCT06101940 · Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (… | Myopathies | Ralentissement de la progression | À vérifier | ENROLLING_BY_INVITATION | Myotonic dystrophy type 1 (DM1) is an autosomal dominant multisystem disor… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:44 | Détail |
| TODDLER — A Remote Study Using Technology to Assess Outcomes in DMD NCT07423026 · NCT07423026 | Myopathies | À vérifier | À vérifier | RECRUITING | Every year, 100 boys are born in the UK with a rare muscle disease called… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:44 | Détail |
| Adult and Juvenile Myositis NCT00017914 · NCT00017914 | Myopathies | Ralentissement de la progression · Immunomodulation · Traitement symptomatique… | À vérifier | RECRUITING | This study will evaluate subjects with adult- and childhood-onset myositis… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Botulinum toxin type A NCT05720065 · Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A | Myopathies | Traitement symptomatique | Phase 2 | RECRUITING | The main purpose of this study is to determine which is the best dose of a… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| CovExc — Muscular Rehabilitation by Eccentric Exercise After Severe C… NCT04649086 · NCT04649086 | Myopathies | À vérifier | Non applicable | TERMINATED | With the COVID-19 pandemic, the number of patients to be treated in rehabi… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Effectiveness of Conservative Interventions in the Treatment of Trigg… NCT06296017 · NCT06296017 | Myopathies | À vérifier | Non applicable | RECRUITING | There is no study in the literature comparing the effectiveness of ESWT an… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Electrophysiological measurement of reflex nociceptive flexion thresh… NCT04624581 · FIbromyalgia anD GenetIcs Subgroups (FIDGIS) | Myopathies | Traitement symptomatique | Non applicable | COMPLETED | Fibromyalgia syndrome (FS) is characterized by widespread pain and affect… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Fascial Distortion Model NCT06627855 · Effectiveness of the Fascial Distortion Model in Temporomandibular Disorders: A… | Myopathies | Ralentissement de la progression · Traitement symptomatique | Non applicable | RECRUITING | The aim of the study was to investigate the effectiveness of Manual Therap… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Intravenously administered pooled human immunoglobulin (IVIG) NCT06599697 · The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Med… | Myopathies | À vérifier | Phase 2 | RECRUITING | This is a randomized, placebo-controlled, double blinded phase 2 explorato… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| LOLA — Effectiveness of Health Education Program on Musculoskeletal P… NCT07160478 · NCT07160478 | Myopathies | Traitement symptomatique | Non applicable | COMPLETED | Musculoskeletal pain during childhood can negatively affect school attenda… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Prospective, Longitudinal, Observational Registry of Adult Patients W… NCT05596539 · NCT05596539 | Myopathies | À vérifier | À vérifier | RECRUITING | The purpose of this study is to assess medical events during follow-up of… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Real radial extracorporeal shock wave therapy (rESWT) NCT07476690 · CP-rESWT-FREQ — Effect of rESWT Session Frequency on Spasticity and Function Ass… | Myopathies | Traitement symptomatique | Non applicable | COMPLETED | Spasticity is a major contributor to functional limitations in children wi… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| SeMAFor — Magnesium, Stress and Fibromyalgia NCT03887000 · NCT03887000 | Myopathies | Traitement symptomatique | Non applicable | COMPLETED | Fibromyalgia affects an average of 2% of the French population. Data from… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| AZD5492 NCT06916806 · TITAN — A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharm… | Lupus | Immunomodulation | Phase 1 | RECRUITING | The purpose of this study is to measure the safety, tolerability, PK, and… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:41 | Détail |
| AOC 1020 NCT05747924 · FORTITUDE — Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral… | Myopathies | À vérifier | Phase 1/2 | COMPLETED | A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluat… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
| BMN 351 NCT06280209 · A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Phar… | Myopathies | À vérifier | Phase 1/2 | ACTIVE_NOT_RECRUITING | This open-label extension study aims to evaluate the long-term safety and… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
| EPI-321 NCT06907875 · FSHD — A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrop… | Myopathies | Thérapie génique | Phase 1/2 | ACTIVE_NOT_RECRUITING | The goal of this clinical trial is to learn how safe and tolerable EPI-321… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
| GNR-097 NCT07673809 · A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therap… | Myopathies | Thérapie génique | Phase 1/2 | RECRUITING | The study will evaluate the tolerability, safety and efficacy of gene ther… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
| PBGENE-DMD (IV) NCT07429240 · PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular… | Myopathies | À vérifier | Phase 1/2 | RECRUITING | The purpose of this Phase 1/2a trial is to evaluate the safety, tolerabili… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 585
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| [Diseases and overuse injuries of the lower extremities in long dista… Utilization of High Frequency Ultrasound to Diagnose Chronic Exertional Compartment Syndrome ·… | Myopathies | Traitement symptomatique | Publication | PubMed | Voir la publication source Running is one of the most popular sports worldwide, with running events attracting hundreds of thousands of runners of… | Zeitschrift fur Rheumatologie 2026-08-13 15:02:07 | Source |
| Expression Defects of SCN5A Common Polymorphisms S524Y and H558R in t… Mexiletine · PMID 42587826 | Myopathies | Thérapie génique | Publication | PubMed | Voir la publication source The cardiac sodium channel Na1.5, encoded by SCN5A, generates the inward sodium current required for myocardial excitab… | Cells 2026-08-13 15:02:06 | Source |
| Universal Metal-Free Deborylation-Deuteration via Redox-Decoupled Tan… Mexiletine · PMID 42561327 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Flow electrochemical synthesis is a promising platform for constructing value-added targets such as d-labeled compounds… | Journal of the American Chemical Society 2026-08-13 15:02:06 | Source |
| Empowered Relief for Youth: Development, feasibility and early effect… Pain Science Education · PMID 42542155 | Myopathies | Traitement symptomatique | Publication | PubMed | Voir la publication source Empowered Relief (ER) is a single-session pain management class that teaches pain science education and self-regulatory… | The journal of pain 2026-08-13 15:02:02 | Source |
| Beyond the first switch: multiple switching, cross-switching, and noc… GenPHSat injection (Safety) · PMID 42590845 | Myopathies | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source In health systems outside the United States (US) with longer biosimilar experience, use has shifted from a question of… | Expert opinion on biological therapy 2026-08-13 15:01:58 | Source |
| Detection of antisense oligonucleotides from biological samples by li… GenPHSat injection (Safety) · PMID 42590939 | Myopathies | Thérapie génique | Publication | PubMed | Voir la publication source This study developed a detection method for antisense oligonucleotides (ASOs) by ligase detection reaction (LDR) using… | BioTechniques 2026-08-13 15:01:58 | Source |
| Grape-Derived Exosome-like Nanoparticles Ameliorate Prediabetes in Mi… Glutamine · PMID 42589601 | Myopathies | Ralentissement de la progression | Publication | PubMed | Voir la publication source This study investigates the effects of grape-derived exosomes on prediabetic mice and elucidates their underlying mecha… | International journal of molecular sciences 2026-08-13 15:01:56 | Source |
| Species Dynamics and Gene Expression in Algal Polycultures Under Mixo… Glutamine · PMID 42590830 | Myopathies | Thérapie génique | Publication | PubMed | Voir la publication source Mixotrophic cultivation of microalgal polycultures can enhance biomass productivity and nutrient recovery from wastewat… | Biotechnology and bioengineering 2026-08-13 15:01:56 | Source |
| Creatine monohydrate supplementation for recovery from muscle disuse:… Creatine Monohydrate · PMID 42539704 | Myopathies | Immunomodulation | Publication | PubMed | Voir la publication source Creatine monohydrate supplementation is best known as an ergogenic aid. However, its potential role in recovery from mu… | Sports medicine and health science 2026-08-13 15:01:55 | Source |
| Effects of creatine supplementation with and without exercise and die… Creatine Monohydrate · PMID 42578920 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Theoretically, CrM supplementation during a weight loss and exercise intervention may help older individuals promote mo… | Journal of the International Society of Sports Nutriti… 2026-08-13 15:01:55 | Source |
| A machine learning approach to predict treatment response in myofasci… trigger point injection · PMID 42572026 | Myopathies | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Trigger point injection (TPI) therapy is widely used for masseter myofascial pain syndrome (MPS), yet outcomes vary sub… | BMC oral health 2026-08-13 15:01:51 | Source |
| Functional recovery after trigger point injection in pediatric anteri… trigger point injection · PMID 42581245 | Myopathies | Traitement symptomatique | Publication | PubMed | Voir la publication source Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) is an under-recognized cause of chronic abdominal pain in children… | European journal of pediatrics 2026-08-13 15:01:51 | Source |
| A pharmacometric framework for norepinephrine transporter occupancy a… Desipramine · PMID 42549822 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Norepinephrine transporter (NET) inhibition is a relevant mechanism across psychotropic medications, although prescribi… | Journal of psychopharmacology (Oxford, England) 2026-08-13 15:01:49 | Source |
| Stepwise Translational Validation of the Screening Hit Desipramine Re… Desipramine · PMID 42587754 | Myopathies | Thérapie cellulaire | Publication | PubMed | Voir la publication source Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease with limited treatment options… | Cells 2026-08-13 15:01:49 | Source |
| Impact of an Antimicrobial Stewardship intervention on clinical and e… Behavioral Interventions for Controlling Oral Behaviors · PMID 42575221 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Urinary tract infections (UTIs) are a common indication for Outpatient Parenteral Antimicrobial Therapy (OPAT) and ofte… | International journal of antimicrobial agents 2026-08-13 15:01:45 | Source |
| Neuroprotective effects of gallic acid against docetaxel-induced peri… Behavioral Interventions for Controlling Oral Behaviors · PMID 42573976 | Myopathies | Neuroprotection · Immunomodulation | Publication | PubMed | Voir la publication source This study focuses on the potential neuroprotective effects of gallic acid (GA) against docetaxel (DOC)-induced periphe… | Molecular and cellular biochemistry 2026-08-13 15:01:45 | Source |
| When Neurodevelopment Meets Autoimmunity: Pemphigus Foliaceus in Rett… IvIg · PMID 42589518 | Myopathies | Immunomodulation | Publication | PubMed | Voir la publication source Rett syndrome (RTT, OMIM 312750) is a complex multisystem neurodevelopmental disorder. Evidence suggests that RTT may h… | International journal of molecular sciences 2026-08-13 15:01:45 | Source |
| Optimizing muscle inset in free functional muscle transfer for facial… Functional muscle transfer · PMID 42585788 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Free functional muscle transfer is a well-established technique for dynamic facial reanimation; however, the inset phas… | Journal of plastic, reconstructive & aesthetic surgery… 2026-08-13 15:01:43 | Source |
| Toward an Integrated Strategy for Volumetric Muscle Loss Regeneration. Functional muscle transfer · PMID 42590005 | Myopathies | Remyélinisation indirecte / réparation · Immunomodulation · Traitement symptoma… | Publication | PubMed | Voir la publication source Volumetric muscle loss (VML) constitutes a significant clinical challenge, defined by the irreversible loss of skeletal… | Journal of clinical medicine 2026-08-13 15:01:43 | Source |
| Capsaicin and diclofenac coloaded nanoemulsion gel optimized by quali… Diclofenac 1% Topical · PMID 42578576 | Myopathies | Immunomodulation · Traitement symptomatique | Publication | PubMed | Voir la publication source Rheumatoid arthritis (RA) is a chronic inflammatory disorder associated with progressive joint damage and pain. The pre… | Therapeutic delivery 2026-08-13 15:01:42 | Source |
Exploration — prudence
Pistes exploratoires 6
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| N-PPG N-PPG — modulation métabolique cérébrale | Myopathies | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Myopat… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |
| Vecteur Ple389 (ADORA2A) MiniPromoter Ple389 — ciblage striatal | Myopathies | Thérapie génique | Hypothèse exploratoire | Rapprochement automatique non validé | Expression génique ciblée dans les neurones striataux Vecteur Ple389 (ADORA2A) est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être per… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |
| α-Amyrin α-Amyrin — protection mitochondriale | Myopathies | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Protection mitochondriale et modulation de la pathologie Tau α-Amyrin est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pour Myopa… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Myopathies | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| Thonningianin A Thonningianin A — neuroprotection anti-amyloïde | Myopathies | Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation du stress oxydatif et des protéines associées à Alzheimer Thonningianin A est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |
| Vutiglabridin Vutiglabridin — autophagie et PON2 | Myopathies | Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Activation de PON2 et stimulation de l’autophagie Vutiglabridin est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pour… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |